SUGAR LAND, Texas--(BUSINESS WIRE)--CVR Energy, Inc. (the "Company†or "CVR Energy†) (NYSE: CVI) announced today that, subject to market conditions, it intends to offer (the "Offering†) for sale in a private placement pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the "Securities Act†), $1 billion in aggregate principal amount of senior unsecured notes due 2031 (the "2031 Notes†) and senior unsecured notes due 2034 (the "2034 Notes†and, together with the 2. ...

Core Viewpoint - Albertsons Companies, Inc. plans to offer $1,250 million in new senior notes due in 2031 and 2034 to raise capital for its operations [1] Group 1: Financial Details - The total amount of new senior notes being offered is $1,250 million [1] - The notes will be issued in two tranches: the 2031 Notes and the 2034 Notes [1] - Co-issuers of the notes include Safeway Inc., New Albertsons L.P., Albertson's LLC, and Albertsons Safeway LLC [1] Group 2: Use of Proceeds - The company intends to use the net proceeds from the offering for its operational needs [1]

Core Viewpoint - Fortescue Treasury Pty Ltd has announced an increase in its Tender Offers to purchase up to US$750,000,000 of its outstanding notes, up from the previously announced US$600,000,000 [2][12] Group 1: Tender Offer Details - The Tender Offers are aimed at purchasing cash for up to US$750,000,000 aggregate principal amount of its outstanding series of notes [2] - The tender cap for the 2031 Notes has been raised from US$400,000,000 to US$500,000,000 [5] - The aggregate principal amount of the 2031 Notes validly tendered exceeded the new tender cap, leading to a proration factor of approximately 44% for accepted purchases [6] - The aggregate principal amount of the 2030 Notes and 2031 Notes validly tendered exceeded the Aggregate Maximum Tender Amount, resulting in a proration factor of approximately 50% for the 2030 Notes [7] Group 2: Early Tender Results - As of the Early Tender Date, the total principal amount tendered for the 2031 Notes was US$1,136,212,000, while for the 2030 Notes it was US$499,839,000 [4] - Holders of the 2030 Notes accepted for purchase will receive US$1,045.00 per US$1,000.00 principal amount, while those for the 2031 Notes will receive US$978.75 per US$1,000.00 principal amount [10] - The settlement date for the accepted notes is expected to be October 22, 2025 [10] Group 3: Additional Information - The Tender Offers will expire at 5:00 p.m. New York City time on November 4, 2025, unless extended or terminated earlier [11] - BofA Securities has been appointed as the Dealer Manager for the Tender Offers, with D.F. King & Co., Inc. acting as the Tender and Information Agent [13]

Group 1 - Novavax has entered into agreements to issue $225 million of 4.625% Convertible Senior Notes due 2031, which includes approximately $175.3 million in exchange for existing 5.00% Convertible Senior Notes due 2027 and approximately $49.7 million for cash [1][2][9] - The conversion price of the 2031 Notes is set at $11.14 per share, representing a 27.5% premium over the closing price on August 20, 2025 [2] - After the transactions, approximately $26.5 million of the 2027 Notes will remain outstanding, while the total principal amount of the 2031 Notes will be $225 million [2][3] Group 2 - The refinancing extends the maturity date of most existing debt to 2031, improving the capital structure of Novavax [3][9] - The company aims to optimize existing partnerships and expand access to its technology platform through R&D innovation and new collaborations [6]